Sunday, December 21, 2014
When it comes to temperature-controlled transportation in particular, there is a perceived lack of performance measurements in the supply chain. For cold chain healthcare shipments, product integrity is paramount with speed a distant second, as temperature excursions could irreversibly damage chemical and biological components.
On March 7th of this year, the European Union issued new guidelines on Good Distribution Practices (GDP) that will take effect in 6 months. An updated version of original guidelines from 1994 was released in 2011 for public consultation. The extensive input of numerous stakeholders led to the new publication focused on medicinal products for human use. Contents do not contain any surprises for professionals who followed developments at cold chain conferences in particular.